To compare morphologic characteristics of type 1 macular neovascularization (MNV) flow pattern in treatment-naïve and previously treated patients with age-related macular degeneration (AMD) as assessed by optical coherence tomography angiography (OCTA).
Study Design
Cross-sectional study
Materials and Methods
Macular OCT angiography images were acquired using RTVue XR Avanti with AngioVue. Distinct morphologic biomarkers and quantifiable features of the neovascular membranes were studied on en-face projection images comparing treatment-naïve and previously treated patients.
Results
The study included 68 eyes of 58 patients. Among them, 24 eyes were treatment-naïve, and the remaining eyes had received a mean of 19.6 injections. Immature lesions were more associated with treatment-naïve eyes and hyper-mature lesions were associated with previously treated eyes (p = 0.005). Tangle pattern was associated with treatment-naïve eyes (p = 0.013), whereas mature core vessels and sea fan pattern were associated more with previously treated eyes (p = 0.001 and p = 0.044, respectively). Vascular density of the neovascular membrane was higher in the treatment-naïve group (p = 0.036) and the average MNV area was similar between the 2 groups (p = 0.683).
Conclusions
Based on OCTA, morphologic biomarkers of type 1 MNV might be an indication of previous treatment. The MNV pattern can improve our understanding of its maturation under anti-VEGF treatment and might be valuable to better guide therapeutic decisions and provide more personalized care to patients with AMD.
MaguireMGAlexanderJFineSLComplications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group. Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial. Ophthalmology [Internet]2008 [cited 2019 Aug 27]; 115: 1468–1473, 1473.e1–2. Available from:http://www.ncbi.nlm.nih.gov/pubmed/18486222.
2.
HolzFGJorzikJSchuttF,et al.Agreement among ophthalmologists in evaluating fluorescein angiograms in patients with neovascular age-related macular degeneration for photodynamic therapy eligibility (FLAP-study). Ophthalmology2003; 110: 400–405.
3.
BrownDMKaiserPKMichelsM, et al.Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med2006; 355: 1432–1444.
4.
AveryRLPieramiciDJRabenaMD,et al.Intravitreal bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmology [Internet]2006 [cited 2019 Aug 27]; 113: 363–372.e5. Available from:https://linkinghub.elsevier.com/retrieve/pii/S0161642005014375.
5.
ArnoldJBarbezettoIBirngruberR, et al.Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in photodynamic therapy report 2. Am J Ophthalmol2001; 131: 541–560.
6.
JungJJChenCYMrejenS, et al.The incidence of neovascular subtypes in newly diagnosed neovascular age-related macular degeneration. Am J Ophthalmol [Internet]2014[cited 2019 Jul 20]; 158: 769–779.e2. Available from:http://www.ncbi.nlm.nih.gov/pubmed/25034111.
7.
SpaideRFJaffeGJSarrafD, et al.Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group. Ophthalmology2020; 127: 616–636.
8.
de CarloTEBonini FilhoMAChinAT, et al.Spectral-Domain optical coherence tomography angiography of choroidal neovascularization. Ophthalmology [Internet]2015 [cited 2019 Jul 12]; 122: 1228–1238. Available from:https://www.sciencedirect.com/science/article/pii/S0161642015001037.
9.
CarnevaliACicinelliMVCapuanoV, et al.Optical coherence tomography angiography: a useful tool for diagnosis of treatment-naïve quiescent choroidal neovascularization. Am J Ophthalmol2016; 169: 189–198.
10.
FaridiAJiaYGaoSS, et al.Sensitivity and specificity of OCT angiography to detect choroidal neovascularization. Ophthalmol Retin2017; 1: 294–303.
11.
CoscasGJLupidiMCoscasF,et al.Optical coherence tomography angiography versus traditional multimodal imaging in assessing the activity of exudative age-related macular degeneration: a new diagnostic challenge. Retina [Internet]2015 [cited 2019 Jul 12]; 35: 2219–2228. Available from:http://www.ncbi.nlm.nih.gov/pubmed/26398697.
12.
KuehleweinLBansalMLenisTL, et al.Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration. Am J Ophthalmol [Internet]2015 [cited 2019 Jul 13]; 160: 739–748.e2. Available from:http://www.ncbi.nlm.nih.gov/pubmed/26164826.
13.
SulzbacherFPollreiszAKaiderA, et al.Identification and clinical role of choroidal neovascularization characteristics based on optical coherence tomography angiography. Acta Ophthalmol [Internet]2017 [cited 2019 Jul 20]; 95: 414–420. Available from:http://www.ncbi.nlm.nih.gov/pubmed/28133946.
14.
XuDDávilaJPRahimiM, et al.Long-term progression of type 1 neovascularization in age-related macular degeneration using optical coherence tomography angiography. Am J Ophthalmol [Internet]2018 [cited 2019 Jul 20]; 187: 10–20. Available from:http://www.ncbi.nlm.nih.gov/pubmed/29269100.
15.
JiaYBaileySTWilsonDJ, et al.Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology [Internet]2014 [cited 2019 Jul 20]; 121: 1435–1444. Available from:http://www.ncbi.nlm.nih.gov/pubmed/24679442.
16.
Al-SheikhMIafeNAPhasukkijwatanaN,et al.Biomarkers of neovascular activity in age-related macular degeneration using optical coherence tomography angiography. Retina [Internet]2018 [cited 2019 Jul 20]; 38: 220–230. Available from:http://www.ncbi.nlm.nih.gov/pubmed/28582276.
17.
ColeEDFerraraDNovaisEA,et al.Clinical trial endpoints for optical coherence tomography angiography in neovascular age-related macular degeneration. Retina [Internet]2016 [cited 2019 Jul 20]; 36: S83–S92. Available from:http://www.ncbi.nlm.nih.gov/pubmed/28005666.
18.
MiereAButoriPCohenSY, et al.Vascular remodeling of choroidal neovascularization after anti–vascular endothelial growth factor therapy visualized on optical coherence tomography angiography. Retina [Internet]2019 [cited 2019 Jul 20]; 39: 548–557. Available from:http://www.ncbi.nlm.nih.gov/pubmed/29210939.
19.
FaesLAliZWagnerS, et al.Effect of total anti-VEGF treatment exposure on patterns of choroidal neovascularisation assessed by optical coherence tomography angiography in age-related macular degeneration: a retrospective case series. BMJ Open Ophthalmol [Internet]2019 [cited 2019 Jul 20]; 4: e000244. Available from:http://www.ncbi.nlm.nih.gov/pubmed/31179393.
20.
CoscasGLupidiMCoscasF,et al.Optical coherence tomography angiography during follow-up: qualitative and quantitative analysis of mixed type I and II choroidal neovascularization after vascular endothelial growth factor trap therapy. Ophthalmic Res [Internet]2015 [cited 2019 Jul 20]; 54: 57–63. Available from:http://www.ncbi.nlm.nih.gov/pubmed/26201877.
21.
SpaideRF. Optical coherence tomography angiography signs of vascular abnormalization with antiangiogenic therapy for choroidal neovascularization. Am J Ophthalmol2015; 160: 6–16.
22.
MuakkassaNWChinATde CarloT, et al.Characterizing the effect of anti-vascular endothelial growth factor therapy on treatment-naive choroidal neovascularization using optical coherence tomography angiography. Retina [Internet]2015 [cited 2019 Jul 20]; 35: 2252–2259. Available from:http://www.ncbi.nlm.nih.gov/pubmed/26457400.
23.
LumbrosoBRispoliMSavastanoMC. Longitudinal optical coherence tomography-angiography study of type 2 naive choroidal neovascularization early response after treatment. Retina2015; 35: 2242–2251.
24.
HuangDJiaYRispoliM,et al.Optical coherence tomography angiography of time course of choroidal neovascularization in response to anti-angiogenic treatment. Retina2015; 35: 2260–2264.
25.
RobertsPKNesperPLGillMK,et al.Semiautomated quantitative approach to characterize treatment response in neovascular age-related macular degeneration: a real-world study. Retina2017; 37: 1492–1498.
26.
SchneiderEWMruthyunjayaPTalwarN,et al.Reduced fluorescein angiography and fundus photography use in the management of neovascular macular degeneration and macular edema during the past decade. Investig Opthalmology Vis Sci [Internet]2014 [cited 2019 Jul 20]; 55: 542. Available from:http://www.ncbi.nlm.nih.gov/pubmed/24346174.
